Praxis Halts Ulixacaltamide Study Over Efficacy; Tesla Drops 25.66% in 2025 Amid EV Concerns; Dell Faces Margin Risks from Tariffs Despite Strong Buy Ratings.
Market-Moving Event Alerts
Remember to move the mail to the Primary inbox if this mail is in other inboxes.
This week, StockNews.AI published 341 successful event alerts across multiple sectors, with nearly 20% driving price movements of over 10% — an impressive streak! This marks the third consecutive week of strong, reliable performance from our sentiment analysis.
*Data Captured Between 2/24 00:00am - 2/28 11:00 am EDT.
*Penny stocks are excluded from the 10%+ price change analysis.
Top 3 AI News you can’t miss for today, 2/28.
GlobeNewsWire
BearishShortTermPRAXEarnings
Praxis Precision Medicines Provides Update on Essential3 and Corporate Update
- IDMC halted Study 1 for ulixacaltamide due to efficacy concerns.
- Praxis will continue remaining studies, expecting results by Q3 2025.
- Company maintains strong cash position, funding operations into 2028.
- Multiple pipeline readouts expected in 2025 for various therapies.
- Fiscal losses increased significantly from 2023 to 2024.
Benzinga
VeryBearishShortTermTSLAIndustry News
Tesla: The Only Magnificent Seven Stock In Freefall - Can It Reverse Course?
- Tesla is down 25.66% in 2025, worst in Magnificent Seven.
- Tesla's forward P/E ratio of 95.24 is significantly higher than competitors.
- Current technical indicators show TSLA trading below key moving averages.
- Tesla's revenue growth lags behind Nvidia and Meta.
- Investors are concerned about EV demand and margin pressures.
Barrons
BearishShortTermDELLCorporate Developments
Dell Stock: Why Tariffs Are Becoming a Concern - Barron's
- Dell's COO says tariffs are a significant risk to margins.
- Earnings per share exceeded estimates, but revenue fell short.
- Analysts maintain strong buy ratings despite tariff concerns.
- Expected margin decline may impact Dell's profitability in 2026.
- Diversified supply chain positions Dell better against tariff impacts.
Here’re the top 5 most-surged stocks captured by our AI Event signal this week.
*Penny stocks are not included in the list.
GlobeNewsWire
BullishLongTerm 64.5%ORGOEarnings
Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results
- ORGO reported Q4 2024 revenue of $126.7 million, up 27% year-over-year.
- Net income for Q4 2024 was $7.7 million, a significant turnaround from loss.
- 2024 fiscal year revenue reached $482 million, an 11% increase from 2023.
- Future plans include the ReNu BLA submission, targeting knee OA treatment.
- Cash reserves increased to $136.2 million with no debt obligations.
GlobeNewsWire
BearishShortTerm -37.74%ARKOEarnings
ARKO Corp. Reports Fourth Quarter and Full Year 2024 Results
- ARKO reported a net loss of $2.3 million in Q4 2024.
- Adjusted EBITDA for 2024 decreased to $248.9 million from $276.3 million.
- Merchandise margin rate increased to 33.0% in Q4 2024.
- The company plans to convert 100 retail stores to dealer sites in 2025.
- A quarterly dividend of $0.03 per share will be paid in March 2025.
PRNewsWire
BullishLongTerm 34.51%RRGBEarnings
Red Robin Gourmet Burgers, Inc. Reports Results for the Fiscal Fourth Quarter and Fiscal Year Ended December 29, 2024
- RRGB reported a 3.4% increase in comparable restaurant revenue.
- Total revenues decreased to $285.2 million compared to $309 million.
- Net loss doubled to $39.7 million, largely due to impairments.
- Adjusted EBITDA rose by 19%, signaling some operational improvements.
- 2025 guidance suggests potential recovery, with revenues projected up to $1.25B.
PRNewsWire
BullishLongTerm 32.63%MEGEarnings
Montrose Environmental Group Reports Record Fourth Quarter and Full Year 2024 Results and Provides Strong 2025 Guidance
- MEG achieved record quarterly revenue of $189.1 million, up 14.1%.
- Net loss increased to $28.2 million, impacted by executive compensation charges.
- Adjusted EBITDA rose 55.8% to $27.2 million, signaling operational efficiency.
- 2025 revenue guidance projects $735.0 million to $785.0 million, indicating growth.
- Shift in U.S. policies may drive demand for MEG’s environmental services.
GlobeNewsWire
VerybullishShortTerm 27.15%EVEREarnings
EverQuote Announces Fourth Quarter and Full Year 2024 Financial Results
- Q4 revenue surged 165% to $147.5M YOY. Strong financial growth noted.
- Automotive revenue climbed over 200% YOY. Net income turned positive.
- Full-year revenue hit $500M with net income of $32.2M. Cash reserves robust.
- Q1 2025 outlook forecasts 73% revenue and 163% EBITDA growth. Guidance is upbeat.
Want to see customized event news?
Subscribe and Activate Event Alert Today!
Disclaimer: The content provided in this Email should be used for informational purposes only and in no way should be relied upon for financial advice.
Reply